EastWest Bioscience Inc. Announces Earnings Results for the Third Quarter Ended April 30, 2021
June 28, 2021 at 10:19 pm
EastWest Bioscience Inc. announced earnings results for the third quarter ended April 30, 2021. For the third quarter, the company announced total revenue was CAD 310,980 compared to CAD 231,248 a year ago. Net loss was CAD 151,866 compared to CAD 374,690 a year ago. For the nine months, total revenue was CAD 935,198 compared to CAD 1.107 million a year ago. Net loss was CAD 671,454 compared to CAD 841,062 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.